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Background: South Asian Canadians experience disproportionately high rates of cardiovascular disease (CVD). The
goal of this qualitative study was to determine the feasibility of implementing a sustainable, culturally adapted,
community-based CVD risk factor screening program for this population.
Methods: South Asians (≥ 45 years) in Calgary, Alberta underwent opportunistic cardiovascular risk factor screening
by lay trained volunteers at local religious facilities. Those with elevated blood pressure (BP) or ≥ 1 risk factor
underwent point of care cholesterol testing, 10-year CVD risk calculation, counseling, and referral to family
physicians and local culturally tailored chronic disease management (CDM) programs. Participants were invited for
re-screening and were surveyed about health system follow-up, satisfaction with the program and suggestions for
improvement. Changes in risk factors from baseline were estimated using McNemar’s test (proportions) and paired
t-tests (continuous measures).
Results: Baseline assessment was completed for 238 participants (median age 64 years, 51% female). Mean TC, HDL
and TC/HDL were 5.41 mmol/L, 1.12 mmol/L and 4.7, respectively. Mean systolic and diastolic blood pressures
(mmHg) were 129 and 75 respectively. Blood pressure and TC/HDL ratios exceeded recommended targets in 36%
and 58%, respectively, and 76% were at high risk for CVD. Ninety-nine participants (47% female) attended re-
screening. 82% had accessed health care providers, 22% reported medication changes and 3.5% had attended the
CDM programs. While BP remained unchanged, TC and TC/HDL decreased and HDL increased significantly (mean
differences: -0.52 mmol/L, -1.04 and +0.07 mmol/L, respectively). Participants were very satisfied (80%) or satisfied
(20%) with the project. Participants suggested screening sessions and CDM programs be more accessible by:
delivering evening or weekends programs at more sites, providing transportation, offering multilingual programs/
translation assistance, reducing screening wait times and increasing numbers of project staff.
Conclusions: SA-CHAMP demonstrated the feasibility and value of implementing a lay volunteer–led, culturally
adapted, sustainable community-based CVD risk factor screening program in South Asian places of worship in
Calgary, Alberta, Canada. Subsequent screening and CDM programs were refined based on the learnings from this
study. Further research is needed to determine physician and patient factors associated with uptake of and
adherence to risk reduction strategies.
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While cardiovascular disease (CVD) rates in Canada have
decreased substantially in recent decades, significant dis-
parities persist among certain ethnic groups. Along with
Aboriginal populations, Canadian South Asians (SAs) ex-
perience CVD morbidity and mortality rates 2 to 5 times
higher than those of European or Chinese descent [1-5].
Furthermore, both the INTERHEART [6] and a recent
study done in Canada [3] suggest that SAs tend to have
their first myocardial infarctions about 5 years earlier, on
average, relative to the general populations in Canada
and elsewhere. These findings mirror those of epidemio-
logical studies from South Africa, Trinidad, Singapore, Fiji,
Mauritius, the United States and the UK (reviewed in:
[7,8]), suggesting that SAs in these countries also carry a
disproportionate CVD burden compared with the general
population.
Modifiable contributors to this disparity in SA’s include
the excessively high (3–5 times higher) prevalence of dia-
betes (including poorly controlled/undetected diabetes),
and metabolic syndrome with dyslipidemias including low
HDL-cholesterol and high triglycerides relative to the gen-
eral populations in these countries [1,7,9-13]. Additional
significant contributors to these observed disparities in-
clude language difficulties, low health literacy, decreased
medication adherence, disparate health beliefs, and lack of
knowledge, understanding and appreciation of the serious
nature of CVD [14-17].
Compared with general public education and social
marketing strategies, better health outcomes result from
interventions that assess individual risk, encourage per-
sonal risk reduction, and put resources in place that cre-
ate a supportive environment for health and strengthen
community action [18-21]. Extensive review of the world
literature suggests that community-based participatory
research (CBPR) methods that tailor interventions to
target barriers specific to a minority group have the
greatest potential to reduce disparities in care and out-
comes [22-30]. Studies undertaken with participants in
their own communities, particularly faith-based interven-
tions involving community health workers or lay health
volunteers and the use of educational materials specially
adapted for the language, culture and literacy needs of the
minority group, showed the greatest promise.
Many exemplar CVD screening and intervention pro-
grams originating in Canada, [31,32] the United States
[25,28,33-35], the United Kingdom [36-38], India [39]
and Pakistan [40] have employed a variety of personnel
(peer educators, community health workers, trained bar-
bers, medical/paramedical volunteers) in religious settings
[19,20,41-45] to improve cardiovascular health among
various minority groups, including African Americans,
Hispanics, older adults and low income women. However,
short of a similar diabetes program [46], to the best of ourknowledge, global CVD risk screening and education pro-
grams for SAs that are led by trained lay community vol-
unteers in religious settings have not been implemented in
Canada.
SAs constitute the second largest visible minority popu-
lation in Canada after those with Chinese origins. Calgary,
Alberta has the third largest visible minority population in
Canada. In 2006, there were over 1.3 million people of SA
ethnicity in Canada; over 60,000 of who lived in Calgary
[47]. Considering the multiple medical and socio-cultural
barriers limiting participation in mainstream programs,
accessible and culturally appropriate CVD prevention,
screening and risk reduction programs for SAs in Canada
are needed.
The objective of this primarily qualitative study was to
determine the feasibility of implementing a sustainable,
culturally adapted, lay volunteer led community-based
CVD risk factor screening program located within places
of worship in the SA (originating from Bangladesh, India,
Pakistan, and Sri Lanka) community in Calgary, Alberta.
Methods
The setting
University of Calgary researchers were approached by
SA community leaders in Calgary, Alberta to implement
a program similar to two local projects that addressed
CVD risk reduction [32,46]. After receiving ethics ap-
proval (from the Calgary’s Conjoint Health Research
Ethics Board) and drawing up a memorandum of under-
standing, six religious facilities were chosen by these
same community leaders as screening locations. Partici-
pation was invited by community leaders through weekly
announcements at the facilities and notices in local com-
munity newsletters, radio and television.
Family physicians
Family physicians adjacent to the screening venues were
invited by letter to a group information and workshop
session. Attendees were provided an overview of the
study and an update on the Canadian guidelines for
hypertension management [48]. Study staff (SM, CAJ,
AN) contacted and discussed the program with physi-
cians who did not attend.
Volunteer training
Forty-nine SA lay community volunteers and allied health
care professionals (2 nurses, 2 dieticians, 2 pharmacists
and 5 medical students) as identified by community
leaders, were provided with a modified version of a vali-
dated culturally adapted volunteer training tool [46] to
read and attended two 3-hour group training sessions
[32]. Volunteers were trained to assess CVD risk and pro-
vide advice, education, family physician referral, and refer-
ral to local culturally tailored chronic disease management
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mation on CVD and major risk factors (unhealthy eating,
physical inactivity, smoking, excess alcohol consumption,
hypertension, dyslipidemia and diabetes). Training in
blood pressure (BP) measurement (BpTRU device (model
BPM 100W:VSM MedTech LTD) and random capillary as-
sessment of total and HDL cholesterol (CholestechW desk
top reflometer, Hayward, CA., USA.) was delivered by a
certified trainer from the Calgary Fire Department [49].
Volunteers were trained to assess 10-year total CVD
risk using the British Hypertension Society CVD Risk
Prediction Chart [50] (http://www.bhsoc.org/Cardiovas-
cular_Risk_Prediction_Chart.stm). As this risk assess-
ment tool underestimates risk among SAs, scores were
multiplied by a factor of 1.5 [51,52]. While this risk assess-
ment tool has not been validated in SAs (nor was any
other at the time of this study), it was chosen because we
were interested in assessing total CVD risk rather than
just coronary heart disease risk (as in the Framingham risk
tool available at the time of the study [53]) and the simple
colored graphics were deemed user friendly for our lay
volunteer group.
University of Calgary, Faculty of Medicine experts pro-
vided clinical expertise and training; a project coordinator
from the community worked with researchers to manage
the volunteers and screening sessions.
Baseline screening
SAs 45 years and older (non-pregnant) presenting for
screening were greeted by a project volunteer who con-
firmed their language of choice and directed then to the
appropriate volunteer for eligibility assessment. All pro-
gram activities were delivered in the participant’s lan-
guage of choice (English, Gujarati, Punjabi, Hindi or the
Dari dialect).
After obtaining signed ethics consent, brief question-
naires assessing personal history of CVD, family history of
premature CVD, smoking status, and presence of known
hypertension, hypercholesterolemia and/or diabetes were
administered. Individuals self-reporting a physician diag-
nosis of or use of medication(s) for high blood pressure,
high cholesterol and/or high blood sugar were considered
to have hypertension, hypercholesterolemia and/or dia-
betes, respectively.
Resting BP was measured as per the Canadian guide-
lines [48] using the automated BPTruW monitor. After five
minutes rest, six readings were obtained at one minute in-
tervals. The first reading was discarded and the average of
the last five was recorded. Those with elevated systolic BP
(≥ 140 mm Hg or ≥ 130 mm Hg among individuals with
diabetes) and/or elevated diastolic BP (≥ 90 mm Hg or ≥
80 mm Hg among those with diabetes) or 1 or more CVD
risk factor (personal history of CVD, family history of
premature CVD, self reported diabetes, hypertension ordyslipidemia, current smoking) were eligible for further
study. Eligible participants underwent non-fasting testing
for total cholesterol/high density lipoprotein (TC/HDL)
ratio and calculation of 10-year total CVD risk. Risk was
classified as low-moderate (≤ 20%) or high (> 20%). Those
with self-reported CVD or diabetes were automatically
classified as high risk. The TC/HDL ratio was considered
within target if < 4 (high risk participants) or < 6 (low-
moderate risk participants) [54].
Screening results and culturally adapted educational
materials [55] detailing CVD risk factors, diet, physical
activity, alcohol and smoking were reviewed with and
then given to participants. Participants were asked to
follow up with their family physicians within one month
of screening. Copies of their assessments were faxed to
their family physicians, with the suggested option of re-
ferring high risk participants to one of three local, cul-
turally sensitive CVD assessment clinics. Low-moderate
risk participants were asked to self-refer to the health re-
gion’s CDM program, consisting of culturally tailored
lifestyle counseling and exercise programs. Community
leaders insisted that all participants receive the same ad-
vice and follow-up recommendations at the same time,
precluding any form of randomization (e.g., to immedi-
ate vs. delayed intervention).
Follow-up screening
After 6–13 months (median = 9 months), participants
who completed baseline assessments were contacted by
telephone and invited for follow-up. Study funding limited
re-screening to the first 100 consecutive participants. They
were re-screened exactly as above, and then completed a
questionnaire assessing reasons for joining the study;
follow-up with family physicians, high risk clinics or CDM
programs; satisfaction with the study and suggestions for
improvement.
Analysis
Changes in BP and cholesterol levels (follow-up minus
baseline) were calculated and average differences (with 95%
confidence intervals) were estimated using McNemar’s test
(proportions) and paired t-tests (continuous variables).
Change was also assessed by subgroup of interest: gender
and self-reported diabetes. All analyses were done using
Stata12 (College Stn, TX).
Results
Baseline screening
Between May 30 and November 15, 2007, 374 partici-
pants attended 12 three hour screening sessions held in
6 different places of worship. Fifty were excluded: < 45 -
years of age (n = 5), age unknown (n = 5), declined BP
measurement (n = 19), declined further participation
after completing health history (n = 13), and currently
Table 1 Demographic and baseline screening information for SA-CHAMP participants
Characteristic All Female Male
N = 238 N = 122 N = 116
n (%) n (%) n (%)
Age (years)
45–59 81 (34) 36 (30) 45 (39)
60–79 142 (60) 79 (65) 63 (54)
80 or older 15 (6) 7 (6) 8 (7)
Program language of choice
English 170 (71) 82 (67) 88 (76)
Gujarati 41 (17) 31 (25) 10 (9)
Punjabi 20 (8) 2 (2) 18 (16)
Dari 4 (2) 4 (3) -
Hindi 3 (1) 3 (3) -
Reported history of CVD* 24 (10) 9 (7) 15 (13)
Reported history of stroke/TIA† 5 (2) 1 (1) 4 (4)
Parent or sibling with myocardial infarction or stroke before age 60 67 (28) 37 (30) 30 (26)
Current smoker or quit within 3 months 11 (5) - 11 (10)
Reported history of hypercholesterolemia 116 (49) 54 (44) 62 (54)
Reported history of diabetes 55 (23) 28 (23) 27 (23)
Reported history of hypertension 124 (52) 70 (57) 54 (47)
Elevated systolic and/or diastolic blood pressure‡ 86 (36) 47 (39) 39 (34)
Controlled TC/HDL § 99 (42) 73 (60) 26 (11)
Estimated 10-year CVD risk
low-moderate (<=20%) 57 (24) 50 (41) 7 (6)
high (>20%) 181 (76) 72 (59) 109 (94)
mean (SD) mean (SD) mean (SD)
range range range
Systolic blood pressure (mmHg) 129 (18.9) 131 (18.8) 127 (18.9)
94-185 97-184 94-185
Diastolic blood pressure (mmHg) 75 (10.4) 74 (9.6) 77 (11.1)
50-116 53-96 50-116
Total cholesterol (mmol/L) 5.41 (1.1) 5.57 (1.2) 5.25 (1.1)
2.59-9.91 2.85-9.91 2.59-9.37








TC/HDL 4.7 (3.8-6.5) 4.4 (3.5-5.4) 5.3 (4.2-7.1)
2.4-16 6 2.4-14.0 2.5-16.7
* CVD: cardiovascular disease.
† TIA: transient ischemic attack.
‡ Elevated systolic blood pressure: > = 140 mm Hg (non-diabetic) or > = 130 mm Hg (diabetic); elevated diastolic blood pressure: > = 90 mm Hg (non-diabetic) or
> = 80 mm Hg (diabetic).
§ Controlled TC/HDL: < 4 for high risk participants; < 6 for low-moderate risk participants.
¶ IQR: interquartile range.
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dred thirty eight were eligible for complete screening.
Men and women were equally represented and had
similar age distributions (Table 1). The majority selected
English as their language of choice. Thirty-six percent
had elevated BP, 58% had elevated TC/HDL ratios, 23%
reported diabetes and 76% were at high risk for CVD.
Compared with women, men were significantly more
likely to have elevated TC/HDL ratios (78% vs. 40%) and
to be at high risk for CVD (94% vs. 59%). Those with
diabetes were more likely than non-diabetics to have
hypertension (measured plus reported) and elevated TC/
HDL ratios (data not shown).
Follow-up screening
Of the 100 individuals who completed follow-up, 1 did not
meet the original study eligibility criteria and was excluded.
While comparable on all other variables (data not shown),
individuals presenting for follow-up had a higher median
TC/HDL ratio when compared with all who presented for
baseline screening (5.2 vs. 4.7).
Mean systolic and diastolic BP did not change from base-
line to follow-up (mean differences: -0.3 mm Hg and
−0.5 mm Hg, respectively) and remained elevated in 35% at
follow-up (Table 2). The average total cholesterol decreased
significantly overall and among all subgroups examined
while the average HDL increased overall and among all
subgroups examined with the exception of those with dia-
betes in whom the average HDL did not change. The aver-
age TC/HDL ratio decreased significantly overall and
among all subgroups examined. While a significant increase
in the proportion of individuals with TC/HDL ratios within
target was noted overall, the improvement appeared to be
limited to men (18%) and those without diabetes (14%)
(Table 2).
All 99 participants completed the evaluation question-
naire. Reasons for taking part in the study included interest
in knowing their BP and cholesterol (35%), desire for
follow-up of a pre-existing health concern (31%) or to
obtain more information about cardiovascular health (22%),
curiosity (18%) and being asked to attend by someone else
(18%). Fifty-eight percent reported being somewhat or a lot
worried by the information that they received. Most (82%)
had visited their family physicians to discuss their results,
with no difference by age, sex, or CVD risk category.
Among these, 66% discussed their CVD risk profiles and
22% had medication changes initiated. Specialty clinic
referrals were made for 31% of high risk participants;
84% attended, 10% did not, and 6% were awaiting appoint-
ments. A search of the CDM program registry revealed
that only 2 of the 57 low-moderate risk participants had
self-referred to the available programs. Time constraints
(44%) and lack of perceived need (9%) were the two most
commonly cited reasons for non-attendance.While all participants reported being very satisfied (80%)
or satisfied (20%) with the project, it was suggested that
screening sessions and CDM programs be made more
accessible by: delivering programs during evening hours or
weekends and at more sites; providing transportation;
offering multilingual programs or translation assistance;
reducing screening wait times and increasing the numbers
of project staff.
Since completion of this program, and based on our
participants’ suggestions, local CDM programs are now
being offered at more sites and with extended hours of
operation. Furthermore, CVD risk screenings have contin-
ued in many of the participating SA communities and have
been refined based on the suggestions made by our SA
CHAMP participants. A community volunteer maintains
the program and has trained several other volunteers. With
the Public Health Agency of Canada’s support, similar
programs piloting screening coupled with “health buddy”
follow-up are ongoing in Calgary and five other cities across
Canada.
Discussion
The SA-CHAMP is unique in that it demonstrated the
feasibility of using trained lay community volunteers to run
a sustainable, culturally adapted opportunistic CVD risk
factor screening project in places of worship within the SA
community in Calgary, Alberta, Canada. Furthermore,
despite this being a pilot trial, modest but significant
improvement in cholesterol measures were noted. Much of
the success and acceptability of this program is a reflection
of the high level of community engagement and volunteer
participation throughout all stages of the program including
the design, implementation and evaluation; key factors in
the well accepted CBPR approach to reducing health
disparities in minority populations [22]. The degree of
community “buy-in” or ownership of the program and the
strong commitment of the lay community members that
has led to the dissemination of the program beyond its
original setting to SA communities across Canada also
makes this program unique in Canada.
Places of worship play a strong cultural and social role in
many communities across the world, and are a place where
community members come together. They have been
shown to provide a particularly relevant and culturally
comfortable setting for health-related interventions
[19,43,44,56,57]. The bulk of this evidence is derived from
studies done in the United States within African American
and Hispanic communities. However, there are two recent
studies other than ours suggesting the feasibility of using
places of worship in SA communities to identify individuals
with CVD risk factors. Davachi et al. [46] demonstrated
that when diabetes screening sessions for those without
known diabetes were held in the context of religious
gatherings in temples and mosques in Calgary, Alberta, it









diastolic blood pressure *
All 99 0.39 0.35 −0.04 (−0.14 to 0.06) 0.524
Men 52 0.38 0.33 −0.06 (−0.21 to 0.10) 0.581
Women 47 0.40 0.38 −0.02 (−0.17 to 0.12) 1.000
Diabetics 27 0.52 0.56 0.04 (−0.22 to 0.30) 0.739
Non-diabetics 72 0.35 0.28 −0.07 (−0.18 to 0.04) 0.267
Controlled TC/HDL§
All 98 0.34 0.46 0.12 (0.01 to 0.23) 0.029
Men 51 0.20 0.37 0.18 (0.03 to 0.33) 0.023
Women 47 0.49 0.55 0.06 (−0.10 to 0.23) 0.581
Diabetics 27 0.30 0.37 0.07 (−0.14 to 0.29) 0.688









All 99 5.56 5.04 −0.52 (−0.71 to −0.34) < 0.001
Men 52 5.34 4.81 −0.53 (−0.81 to −0.24) < 0.001
Women 47 5.81 5.30 −0.52 (−0.76 to −0.28) <0.001
Diabetics 27 5.45 5.13 −0.32 (−0.63 to −0.01) 0.043
Non-Diabetics 72 5.61 5.01 −0.60 (−0.83 to −0.37) <0.001
HDL Cholesterol
All 98 1.08 1.15 0.07 (0.03 to 0.11) 0.002
Men 51 0.96 1.03 0.06 (0.00 to 0.12) 0.038
Women 47 1.21 1.29 0.08 (0.01 to 0.14) 0.029
Diabetics 27 1.08 1.11 0.04 (0.06 to 0.13) 0.456
Non-Diabetics 71 1.09 1.17 0.08 (0.03 to 0.13) 0.002
TC/HDL
All 98 5.80 4.76 −1.04 (−1.41 to −0.68) <0.001
Men 51 6.34 5.03 −1.31 (−1.92 to −0.69) <0.001
Women 47 5.21 4.46 −0.76 (−1.13 to −0.38) <0.001
Diabetics 27 5.85 4.98 −0.87 (−1.70 to −0.04) 0.041
Non-Diabetics 71 5.78 4.67 −1.11 (−1.51 to −0.71) <0.001
* Elevated systolic blood pressure: > = 140 mm Hg (non-diabetics) or > = 130 mm Hg (diabetics); elevated diastolic blood pressure: > = 90 mm Hg (non-diabetics)
or > = 80 mm Hg (diabetics).
§ Controlled TC/HDL: < 4 for high risk participants; < 6 for low-moderate risk participants.
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is reflected in the high participation rate (922 screened
in 14 four hour screening sessions). Similarly, Rao et al.
[45] screened for CVD risk in two Hindu temples in
London, England. In this study medical/paramedical
community members were able to screen 434 self-selected
participants in 9 six-hour sessions. This group is currently
carrying out a qualitative assessment of the acceptability
of the program among staff and participating community
members.Use of trained lay health workers as part of the health-
care team in community-based program settings is
recognized as a way to improve access and the health of
underserved populations [22]. Community members
trained as peer health advisors, particularly those who are
members of the target community, may play a significant
role in addressing cardiovascular risk factors because of
their connectedness to individuals and communities, as
well as their understanding of cultural and contextual
issues [28,58,59]. A noteworthy example is the recent
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trained and paid to become health educators, monitor BP,
and promote physician referral for patrons of local
African-American-owned barbershops in Dallas County,
Texas, USA. While improvement in the primary outcome
of hypertension among African-American male patrons
was modest (8.8%, 95% confidence interval: 0.8%-16.9%),
98% of participants and all 29 participating barbers
reported that they would like the program continued
indefinitely.
Until recently, there has been a paucity of literature on
the effectiveness of trained lay community members as
volunteers, specifically in the context of community-based
CVD risk factor screening and improved CVD outcomes.
In a cluster randomized controlled trial of 39 communities
in Ontario, Canada [31], volunteer lay seniors were trained
to perform BP and cardiovascular risk assessment on other
seniors invited by their physicians to attend pharmacy-
based screening clinics. Within one year of the screening
program, a 9% relative reduction in CVD-related hospital
admissions was noted, translating to 3.02 fewer
hypertension-related hospitalizations per 1000 people aged
65 and older in the intervention communities. Our study
and that of Davachi et al. [46] differ from the Kaczorowski
study in that they were both adapted for the SA community
and as such, the lay trained volunteers were SA and the
screenings took place in religious facilities rather than
community pharmacies. The use of trained lay community
volunteers in this setting shows promise and our study
helps to support the feasibility of implementing a similar
larger RCT in SA communities to evaluate whether such
an intervention can reduce CVD in this group.
The value (in terms of identifying at-risk individuals that
would benefit from intervention) of opportunistic CVD risk
screening in SA places of worship has not been well
described. Using a methodology similar to ours, Davachi
et al. [46] opportunistically screened adult non-diabetic SA
for diabetes in places of worship, and observed very high
rates of obesity (67%), family history of diabetes (43%) and
results suggestive of potential glucose intolerance (36%).
Despite excluding of those with self reported CVD, hyper-
tension, diabetes or use of lipid therapy, [45] Rao et al.
found that 52% of participants had hypertension, 75% had
central obesity, 10% had TC/HDL ratios > 6, and 15% were
assessed as high risk using the QRISK2 model for 10-year
CVD risk. The higher prevalence of both poorly controlled
risk factors and 10-year CVD risk among participants in
our study are consistent with their higher average age and
their relatively high prevalence of self-reported CVD (10%),
diabetes (23%), hypertension (52%) and dyslipidemia (49%).
While these three studies are not directly comparable
given the variable inclusion criteria, screening techniques,
ages and ethnic groups represented, a high prevalence of
modifiable, poorly controlled CVD risk in the SAs thatself-presented for screening was a consistent finding. The
majority of participants were at moderate to high risk for
CVD and therefore represented an ideal target group
for improving awareness and risk factor management.
Further, participants in our study were satisfied with the
program and barriers to healthcare provider access did
not appear to be a problem. Overall, these three studies
provide support for the feasibility, acceptability and value
of screening SA adults for CVD risk factors in places
of worship.
Our study has limitations. Participants self-selected for
study and it is not known if participants in this study are
representative of the SA community at large. Self-selected
participants may have been more motivated, particularly
those who returned for follow-up, which could partially
explain the observed reduction in TC/HDL ratios and high
rates of follow-up with family physicians. Our study design
(single group, before-and-after) was also vulnerable to
regression to the mean. While significant TC/HDL ratio
reductions were still observed when the analysis was
limited to those without outlying values at baseline, random
variation, rather than follow-up care, may explain some of
the observed improvements in lipid control. Furthermore,
while there are small variations in lipid measures between
the CholestechW desk top reflometer and full laboratory-
based lipid profiles, especially in the case of elevated triglyc-
erides, CholestechW measures are considered acceptable
under these circumstances [60]. However, we cannot rule
out such variability as contributing a measure of uncer-
tainty to our cholesterol measures. Additionally, relying on
a single measure of blood pressure at baseline may have led
to an overestimation of the prevalence of hypertension
among those screened.
With respect to data collection, we had no way of valid-
ating self-reported information. The validity of self-report
of CVD risk factors and follow-up behavior in the context
of reporting such sensitive information to a community
volunteer possibly known to the participant is an interest-
ing area for future study. Further, the study protocol
depended to a great extent on trained lay volunteers and
may not be generalizable to all SA communities where
volunteerism is not as prevalent.
Given that this study was primarily qualitative, and that
no a priori power/sample size calculation was performed,
the significance of the pre-post changes (or lack thereof)
in clinical parameters should not be over-interpreted.
These analyses were conducted on an exploratory basis
only. The variability in the studies measures will be used
to determine a sample size for a future, larger study.
Finally, while modified versions of the program have
been initiated in Calgary and 5 other cities in Canada, it
is not yet known if the programs will prove feasible on a
large and sustainable scale and demonstrate effectiveness
within the target population.
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SA-CHAMP demonstrated the feasibility of implementing
a culturally adapted, sustainable community-based CVD
risk factor screening program in the SA community in
Calgary, Alberta, Canada. SA-CHAMP identified a high
risk cohort amenable to intervention. Participants’ input
has helped to refine the next iteration of screening
programs and has helped change policy for the delivery of
local CDM programs. Further research is needed to deter-
mine the content and delivery of sustainable intervention
programs that will successfully reduce CVD risk factors
and disease risk in this population.
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